Schemic Concepts
Anti-Infectives / Critical Care

Mertazo 1.5

Meropenem (1gm) + Tazobactam (500mg)

Mertazo 1.5 pack
← Back to Products
Request Samples
New LaunchRx Only

About this product

Dependable broad-spectrum coverage for resistant hospital infections, including HAP/VAP, complicated intra-abdominal infections, complicated UTI/pyelonephritis, and severe sepsis pending culture guidance.

Composition
Meropenem (1gm) + Tazobactam (500mg)
Mertazo 1.5 composition as printed on the pack
As printed on the pack
Therapy Area
Anti-Infectives / Critical Care
Formulation
Injection
Pack
1.5gm/20ml Vial
Storage
≤ 25°C

Overview

Mertazo 1.5 combines meropenem with tazobactam, giving dependable carbapenem-class cover with added beta-lactamase inhibition for genuinely severe or suspected multidrug-resistant hospital infections. As a reserve-line antibiotic, it is positioned strictly within antimicrobial stewardship protocols.

Indications

Severe hospital-acquired / ventilator-associated pneumonia
Complicated intra-abdominal infections
Complicated UTI / pyelonephritis
Severe sepsis pending culture-directed therapy
Febrile neutropenia, per institutional protocol
Rx only. For use under medical supervision. Intended for healthcare professionals in India.

Related Products

Aztronaz 1g pack

Aztronaz 1g

Aztreonam (1gm)

Targeted gram-negative coverage against E. coli, Klebsiella, and Pseudomonas for serious UTI, respiratory, intra-abdominal, gynaecological, skin, and bloodstream infections.

Cilbactam 1.5 pack

Cilbactam 1.5

Ampicillin (1gm) + Sulbactam (500mg)

Broad single-agent coverage against gram-positive, gram-negative, and anaerobic infections, including skin, intra-abdominal, and gynaecological infections such as PID and endometritis.

Partner With Schemic Concepts

Engineer better health outcomes with precision-driven pharmaceuticals

Healthcare is moving toward greater digital integration and evidence-based care. Schemic Concepts is built to move with it

Partner With Us